We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+0.67%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$743B
AUM Growth
+$17B
Cap. Flow
+$20.9B
Cap. Flow %
2.82%
Top 10 Hldgs %
22.73%
Holding
4,944
New
223
Increased
2,961
Reduced
1,210
Closed
86

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$887M
2
AMZN icon
Amazon
AMZN
+$857M
3
AAPL icon
Apple
AAPL
+$844M
4
MSFT icon
Microsoft
MSFT
+$802M
5
TSLA icon
Tesla
TSLA
+$606M

Sector Composition

Rank Sector Weight
1 Technology 24.53%
2 Financials 13.97%
3 Healthcare 13.42%
4 Consumer Discretionary 11.85%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEHL icon
4801
Antelope Enterprise Holdings
AEHL
$6.12M
0
AWX icon
4802
Avalon Holdings
AWX
$11.2M
$40K ﹤0.01%
10,366
UK icon
4803
Ucommune International Ltd Class A Ordinary Shares
UK
$1.52M
$40K ﹤0.01%
20
SOGP
4804
Sound Group
SOGP
$48.1M
$39K ﹤0.01%
1,261
DBGI
4805
Digital Brands Group
DBGI
$9.08M
0
AVX
4806
Avax One Technology Ltd
AVX
$23.2M
0
CYTO
4807
DELISTED
Altamira Therapeutics Ltd
CYTO
$37K ﹤0.01%
47
ARMP icon
4808
Armata Pharmaceuticals
ARMP
$156M
$36K ﹤0.01%
10,188
XNET
4809
Xunlei
XNET
$321M
$36K ﹤0.01%
12,614
-12,080
-49% -$43K
GRCE
4810
Grace Therapeutics
GRCE
$44.6M
$36K ﹤0.01%
3,058
EVK
4811
DELISTED
Ever-Glory International Group, Inc.
EVK
$36K ﹤0.01%
13,112
NCEL
4812
NewcelX Ltd
NCEL
$17.2M
$35K ﹤0.01%
+36
New +$38.5K
PETZ icon
4813
TDH Holdings
PETZ
$15.9M
$34K ﹤0.01%
1,351
BNKK
4814
Bonk Inc
BNKK
$8.68M
$33K ﹤0.01%
687
MITO
4815
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$33K ﹤0.01%
+24,502
New +$33.2K
BTOG icon
4816
Bit Origin
BTOG
$2.32M
$32K ﹤0.01%
17
PXS icon
4817
Pyxis Tankers
PXS
$50.4M
$32K ﹤0.01%
10,641
GDC icon
4818
GD Culture Group
GDC
$7.28M
$31K ﹤0.01%
3
+1
+50% +$12.2K
SLHG
4819
DELISTED
Skylight Health Group Inc Common Shares
SLHG
$31K ﹤0.01%
+12,822
New +$41.9K
DTSS icon
4820
Datasea Intelligent Technology Ltd
DTSS
$7.68M
$30K ﹤0.01%
975
+276
+39% +$9.59K
MAMA icon
4821
Mama's Creations
MAMA
$828M
$30K ﹤0.01%
+12,805
New +$33.4K
SCNI
4822
Scinai Immunotherapeutics
SCNI
$1.22M
$30K ﹤0.01%
138
PME
4823
DELISTED
Pingtan Marine Enterprise Ltd.
PME
$30K ﹤0.01%
41,107
YTRA icon
4824
Yatra Online
YTRA
$54.1M
$29K ﹤0.01%
14,712
RDGT
4825
Ridgetech Inc
RDGT
$3.33M
$29K ﹤0.01%
1

Similar funds

Geode Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
  • Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
  • Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
  • Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
  • Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
  • Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
  • Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.

Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.